Publications by authors named "Martin Jenkins"

Claim this Profile
F
Frequent productive cough in COPD relates to exacerbation risk and treatment benefit from budesonide/glycopyrrolate/formoterol fumarate: a post hoc analysis of KRONOS.
Mehul Patel, Jonathan Marshall, Fernando J Martinez, Alec Mushunje, Karin Bowen, Martin Jenkins

Respir Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations between the EQ-5D-5L and exacerbations of chronic obstructive pulmonary disease in the ETHOS trial.
Dan Jackson, Martin Jenkins, Enrico de Nigris, Debasree Purkayastha, Mehul Patel

Qual Life Res· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Past, present, and future of the Living Planet Index.
Sophie E H Ledger, Jonathan Loh, Rosamunde Almond, Monika Böhm, Christopher F Clements, Martin Jenkins

NPJ Biodivers· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefits of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate on COPD Exacerbations, Lung Function, Symptoms, and Quality of Life Across Blood Eosinophil Ranges: A Post-Hoc Analysis of Data from ETHOS.
Mona Bafadhel, Klaus F Rabe, Fernando J Martinez, Dave Singh, Patrick Darken, Martin Jenkins

Int J Chron Obstruct Pulmon Dis· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of inhaled budesonide/formoterol fumarate dihydrate delivered via two different devices on lung function in patients with COPD and low peak inspiratory flow.
Bärbel Huber, Claus Keller, Martin Jenkins, Abid Raza, Magnus Aurivillius

Ther Adv Respir Dis· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive modeling of COPD exacerbation rates using baseline risk factors.
Dave Singh, John R Hurst, Fernando J Martinez, Klaus F Rabe, Mona Bafadhel, Martin Jenkins

Ther Adv Respir Dis· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between prior inhaled corticosteroid use and benefits ofbudesonide/glycopyrronium/formoterol fumarate dihydrate on exacerbations, symptoms, health-related quality of life, and lung function in patients with chronic obstructive pulmonary disease: Analyses from the ETHOS study.
Dave Singh, Klaus F Rabe, Fernando J Martinez, Matthias Krüll, Martin Jenkins

Respir Med· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between risk, cumulative burden of exacerbations and mortality in patients with COPD: modelling analysis using data from the ETHOS study.
Kirsty Rhodes, Martin Jenkins, Enrico de Nigris, Magnus Aurivillius, Mario Ouwens

BMC Med Res Methodol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvements in lung function with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler dual therapies in patients with COPD: a sub-study of the ETHOS trial.
Klaus F Rabe, Fernando J Martinez, Dave Singh, Roopa Trivedi, Martin Jenkins

Ther Adv Respir Dis· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefits of budesonide/glycopyrrolate/formoterol fumarate (BGF) on symptoms and quality of life in patients with COPD in the ETHOS trial.
Fernando J Martinez, Klaus F Rabe, Gary T Ferguson, Jadwiga A Wedzicha, Roopa Trivedi, Martin Jenkins

Respir Med· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining 'research inspired teaching' and introducing a research inspired online/offline teaching (riot) framework for fostering it using a co-creation approach.
Sally Pezaro, Martin Jenkins, Martin Bollard

Nurse Educ Today· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A scintigraphy study of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in patients with moderate-to-very severe chronic obstructive pulmonary disease.
Omar Usmani, Nicolas Roche, Ezanul Wahab, Samuel Israel, Martin Jenkins

Respir Res· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional respiratory imaging assessment of budesonide/glycopyrrolate/formoterol fumarate and glycopyrrolate/formoterol fumarate metered dose inhalers in patients with COPD: the value of inhaled corticosteroids.
Maarten van den Berge, Jan De Backer, Cedric Van Holsbeke, Wilfried De Backer, Roopa Trivedi, Martin Jenkins

Respir Res· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional respiratory imaging assessment of glycopyrrolate and formoterol fumarate metered dose inhalers formulated using co-suspension delivery technology in patients with COPD.
Wilfried De Backer, Jan De Backer, Ilse Verlinden, Glenn Leemans, Cedric Van Holsbeke, Martin Jenkins

Ther Adv Respir Dis· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of LAMA/LABA Fixed-Dose Combination Therapies in Chronic Obstructive Pulmonary Disease: A Systematic Review of Direct and Indirect Treatment Comparisons.
John R Hurst, Kevin Gruffydd-Jones, Mousumi Biswas, Deniz Guranlioglu, Martin Jenkins

Int J Chron Obstruct Pulmon Dis· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consistent Pulmonary Drug Delivery with Whole Lung Deposition Using the Aerosphere Inhaler: A Review of the Evidence.
Omar S Usmani, Nicolas Roche, Martin Jenkins, Neda Stjepanovic, Peter Mack

Int J Chron Obstruct Pulmon Dis· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Budesonide/Glycopyrronium/Formoterol Fumarate versus Other Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysis.
Arnaud Bourdin, Nicolas Molinari, Gary T Ferguson, Barinder Singh, Mohd Kashif Siddiqui, Martin Jenkins

Adv Ther· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Lung Function versus Monotherapies in GOLD Category A Patients with COPD: Pooled Data from the Phase III PINNACLE Studies.
Fernando J Martinez, Klaus F Rabe, Brian J Lipworth, Samir Arora, Martin Jenkins

Int J Chron Obstruct Pulmon Dis· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic review and network meta-analysis of the efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler in comparison with other long-acting muscarinic antagonist/long-acting β-agonist fixed-dose combinations in COPD.
Mohd Kashif Siddiqui, Pragya Shukla, Martin Jenkins, Mario Ouwens, Deniz Guranlioglu

Ther Adv Respir Dis· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefits of glycopyrrolate/formoterol fumarate metered dose inhaler (GFF MDI) in improving lung function and reducing exacerbations in patients with moderate-to-very severe COPD: a pooled analysis of the PINNACLE studies.
Fernando J Martinez, Brian J Lipworth, Klaus F Rabe, David J Collier, Gary T Ferguson, Martin Jenkins

Respir Res· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycopyrrolate/formoterol fumarate metered dose inhaler for maintenance-naïve patients with chronic obstructive pulmonary disease: a post-hoc analysis of the randomized PINNACLE trials.
Jinping Zheng, Jin-Fu Xu, Martin Jenkins, Pryseley Nkouibert Assam, Lijiao Wang

Respir Res· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized, Double-Blind, Double-Dummy Study of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Relative to Umeclidinium/Vilanterol Dry Powder Inhaler in COPD.
François Maltais, Gary T Ferguson, Gregory J Feldman, Gaëtan Deslee, Arnaud Bourdin, Martin A Jenkins

Adv Ther· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized study using functional respiratory imaging to characterize bronchodilator effects of glycopyrrolate/formoterol fumarate delivered by a metered dose inhaler using co-suspension delivery technology in patients with COPD.
Wilfried De Backer, Jan De Backer, Wim Vos, Ilse Verlinden, Cedric Van Holsbeke, Martin Jenkins

Int J Chron Obstruct Pulmon Dis· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tissue metabolite of type I collagen, C1M, and CRP predicts structural progression of rheumatoid arthritis.
Anne C Bay-Jensen, Adam Platt, Martin A Jenkins, Michael E Weinblatt, Inger Byrjalsen

BMC Rheumatol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Translational Biomarkers and Ex Vivo Models of Joint Tissues as a Tool for Drug Development in Rheumatoid Arthritis.
Cecilie F Kjelgaard-Petersen, Adam Platt, Martin Braddock, Martin A Jenkins, Kishwar Musa

Arthritis Rheumatol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis